Path-Away is so safe it is exempt from registration under the EPA’s and CDC joint guidance issued by the EPA.
On January 12, 2015, prior to this ruling, “Path-Away Anti-Pathogenic Aerosol Solution” was already declared “exempt from registration” by qualifying as a minimum risk pesticide as defined under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) section 25(b), outlined in title 40 of the Code of Federal Regulations (CFR), section 152.25, and in title 3, California Code of Regulations section 6147. Path-Away Anti-Pathogenic Aerosol Solution is an organic based solution certified with “Organic Input” with “no GMO” components and meets registration regulations on a global basis. (See Approval Letter here).
Path-Away Anti-Pathogenic Aerosol Solution, registered with the United States of America Patent and Trademark Office, #4,032,774, was scientifically developed by Arthur V. Martin, Ph.D., president of Global Infection Control Consultants, LLC. It is a broad spectrum anti-pathogenic product with proven efficacy against 170+ individual pathogens including a wide range of fungi, bacteria, yeasts and viruses including H1N1, Mycobacterium tuberculosis, and others. Path-Away Anti-Pathogenic Aerosol Solution received this rare exemption due to its high efficacy combined with extremely low toxicity. It has been successfully and safely utilized in numerous consumer products as an anti-bacterial agent.
Path-Away Anti-Pathogenic Aerosol Solution is available through a very select group of globally based representatives and N-PE is an approved and authorized representative.